Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 3.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,628 shares of the company’s stock after selling 244 shares during the period. Vontobel Holding Ltd.’s holdings in Henry Schein were worth $556,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Swedbank AB acquired a new stake in shares of Henry Schein in the first quarter valued at approximately $215,998,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Henry Schein in the 2nd quarter worth $46,683,000. SG Americas Securities LLC increased its stake in shares of Henry Schein by 1,622.3% in the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after acquiring an additional 432,187 shares during the last quarter. Nuance Investments LLC raised its holdings in shares of Henry Schein by 28.5% during the 1st quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock worth $132,552,000 after acquiring an additional 388,843 shares during the period. Finally, Magnetar Financial LLC boosted its position in shares of Henry Schein by 229.9% during the 1st quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock valued at $29,185,000 after acquiring an additional 269,330 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.14% of the stock is owned by company insiders.

Henry Schein Trading Down 1.1 %

NASDAQ HSIC opened at $71.59 on Tuesday. Henry Schein, Inc. has a one year low of $60.01 and a one year high of $82.63. The firm has a 50 day simple moving average of $70.47 and a 200-day simple moving average of $69.84. The firm has a market cap of $9.17 billion, a price-to-earnings ratio of 24.19, a PEG ratio of 1.98 and a beta of 0.86. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. During the same quarter in the previous year, the firm posted $1.31 earnings per share. The company’s quarterly revenue was up .0% compared to the same quarter last year. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have commented on HSIC shares. UBS Group reduced their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. JPMorgan Chase & Co. reduced their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Finally, Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Friday, September 20th. One research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein currently has an average rating of “Hold” and an average price target of $77.50.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.